share_log

4 Stocks Under $2 Insiders Are Aggressively Buying

4 Stocks Under $2 Insiders Are Aggressively Buying

4 美元以下的股票 $2 內部人正在積極購買
Benzinga Real-time News ·  2022/04/28 08:20

US crude oil futures traded lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades.

美國原油期貨週四今早走低。與此同時,投資者專注於一些值得注意的內幕交易。

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

當內部人士購買或出售股票時,表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以認為這是他們整體投資或交易決策的一個因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是最近一些細價股的著名內幕交易。有關更多信息,請查看 Beninga 的內部交易平台。

Bluejay Diagnostics

藍傑診斷

  • The Trade: Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Chief Financial Officer Kenneth Fisher acquired a total of 20,000 shares at an average price of $0.99. To acquire these shares, it cost $19.8 thousand.
  • What's Happening: Bluejay Diagnostics recently posted a Q1 loss of $0.10 per share.
  • What Bluejay Diagnostics Does: Bluejay Diagnostics Inc develops, manufactures and markets innovative clinical diagnostic products that improve the quality of medical diagnoses by developing Point-of-Care tests that provide convenience, timeliness, compliance and low cost to physicians and patients in areas where timeliness of the initial triage assessment has a high impact on course of treatment.
  • 貿易: 藍傑診斷有限公司 (NASDAQ:BJDX)首席財務官肯尼思費舍爾以 0.99 美元的平均價格購買了共 20,000 股股票。為了收購這些股票,它的成本 $19.8 萬。
  • 發生了什麼事: 藍傑診斷最近發布了每股 0.10 美元的第一季度虧損。
  • 藍傑診斷做什麼: Bluejay Dinotics Inc 開發、製造和銷售創新的臨床診斷產品,透過開發點照護測試來改善醫學診斷品質,在初始分診評估的及時性對治療過程有很大影響的領域,為醫師和患者提供便利、及時性、合規性和低成本。

Rise Gold

上升金

  • The Trade: Rise Gold Corp. (OTC:RYES) Director Lawrence W. Lepard acquired a total of 216,500 shares at an average price of $0.51. The insider spent around $110.59 thousand to buy those shares.
  • What's Happening: Rise Gold recently reported progress on Idaho-Maryland use permit.
  • What Rise Gold Does: Rise Gold Corp is a mineral exploration stage mining company and its primary asset is a major past producing Idaho-Maryland Gold Mine property near Grass Valley, California, United States.
  • 貿易: 瑞金公司 勞倫斯·勒帕德董事以 0.51 美元的平均價格收購了共 216,500 股股份。內部人士花費了大約 110.59 萬美元購買這些股票。
  • 發生了什麼:黃金漲幅最近報導了愛達荷馬里蘭州使用許可證的進展。
  • 什麼上漲黃金呢: Rise Gold Corp 是一家礦產勘探階段開採公司,其主要資產是在美國加利福尼亞州草谷附近生產愛達荷馬里蘭金礦物業的重要過去。

Also check this: Executives Buy Around $413M Of 3 Stocks

還要檢查這一點:高管購買 3 隻股票的 3 億美元左右

Don't forget to check out our premarket coverage here .

別忘了在這裡查看我們的售前保障。

Augusta Gold

奧古斯塔金

  • The Trade: Augusta Gold Corp. (OTC:AUGG) Director Augusta Investments Inc acquired a total of 22,500 shares at an average price of $1.14. To acquire these shares, it cost around $25.61 thousand.
  • What's Happening: The company's stock has gained 35% since the start of the year.
  • What Augusta Gold Does: Augusta Gold Corp is an exploration stage company. The company is primarily engaged in the acquisition and exploration of gold properties.
  • 貿易: 奧古斯塔黃金 奧古斯塔投資有限公司董事以 1.14 美元的平均價格收購了總共 22,500 股股票。要收購這些股票,其成本約為 25.61 萬美元。
  • 發生了什麼:自今年年初以來,該公司的股票上漲了 35%。
  • 奧古斯塔黃金做什麼: 奧古斯塔黃金公司是一家勘探階段公司。該公司主要從事黃金物業的收購和勘探。

Accustem Sciences

指控科学

  • The Trade: Accustem Sciences Inc. (OTC:ACUT) Director Gabriele M Cerrone acquired a total of 9,447 shares at an average price of $1.43. The insider spent $13.49 thousand to buy those shares.
  • What's Happening: AccuStem recently reported a private placement of common stock.
  • What Accustem Sciences Does: Accustem Sciences Inc is a life sciences company dedicated to optimizing outcomes for all patients with cancer across the globe.
  • 貿易: 指控科學公司 (OTC:ACUT)董事加布里埃爾·塞羅內以 1.43 美元的平均價格購入了 9,447 股。內幕人士花了 13.49 萬美元購買這些股票。
  • 發生了什麼: AccuStem 最近報告了私募普通股。
  • 什麼指控科學做: Accutem Sciences Inc 是一家生命科學公司,致力於優化全球所有癌症患者的結果。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論